Clinical Trials Logo

Filter by:
NCT ID: NCT06223906 Recruiting - Clinical trials for Cardiovascular Diseases

A Registry Study of Biomarkers in Heart Valve Disease

BIOMS-HVD
Start date: January 1, 2016
Phase:
Study type: Observational

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

NCT ID: NCT06223841 Recruiting - Clinical trials for Advanced Malignant Tumors

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Start date: March 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients with Advanced Malignant Tumors.

NCT ID: NCT06223646 Recruiting - Multiple Myeloma Clinical Trials

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

Start date: January 11, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open-label, dose-escalation/expansion phase 1/2a study to evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic characteristics and determine the recommended dose of KQ-2003 CAR T-cells for patients with Relapsed/Refractory Multiple Myeloma

NCT ID: NCT06223308 Recruiting - Cervical Cancer Clinical Trials

A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors

Start date: September 9, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

It is a phase I/II open label, multicenter study to assess the safety, tolerability, pharmacokinetics, and efficacy of HB0028 in patients with advanced solid tumors.

NCT ID: NCT06223256 Recruiting - Clinical trials for Advanced Solid Tumor

A Study of NBL-028 in Patients With Advanced Solid Tumors

Start date: March 8, 2024
Phase: Phase 1
Study type: Interventional

This is a multi-center, single agent study conducted in patients with advanced solid tumor types known to express Claudin 6 (CLDN6) for whom standard of care therapies are not available, are no longer effective, or not tolerated. This study consists two stages: dose-escalating and dose-expansion. Dose escalation will be guided by the Bayesian optimal interval (BOIN) design including accelerated titration to determine the maximum tolerated dose (MTD) of NBL-028. Dose expansion - Additional patients (no more than 200) will be enrolled at the recommended dose or multiple doses (if necessary) determined in the dose escalation stage. Sponsor may elect to enroll specific tumor types into four cohorts.

NCT ID: NCT06223230 Recruiting - Clinical trials for Digestive System Neoplasm

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Aims to observe and evaluate the impact of survival and quality of life of patients with gastrointestinal tumors such as advanced esophageal, gastric, liver, pancreatic, and colorectal cancers through nutritional-psychological interventions versus no-vomit management compared to standard antitumor therapy alone

NCT ID: NCT06223217 Recruiting - Clinical trials for Peripheral Arterial Disease

Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.

Start date: October 1, 2023
Phase:
Study type: Observational

The purpose of this study is to assess the utility of the Modified version of VascuQol Scale as an effective biopsychosocial assessment tool for patients suffering from lower extremity peripheral arterial disease.

NCT ID: NCT06223178 Recruiting - Clinical trials for Diminished Ovarian Reserve

Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve

Start date: November 3, 2023
Phase: N/A
Study type: Interventional

Diminished Ovarian Reserve (DOR) is characterized as an important cause of infertility. Acupuncture has been extensively used to treat female infertility. This study was conducted to investigate the efficacy of thumb-tack needle,as a new special type of acupuncture and long-lasting treatment modality,in the treatment of DOR.

NCT ID: NCT06222983 Recruiting - Clinical trials for Carotid Artery Plaque

Efficacy and Prognosis of Surgical Intervention in Patients With Carotid Artery Stenosis

Start date: December 31, 2023
Phase:
Study type: Observational [Patient Registry]

This study is a prospective, single center cohort study. By combining pathological examination of carotid atherosclerotic plaque with preoperative imaging examination, we explore the imaging characteristics of high-risk carotid plaque, and explore the effectiveness and safety of different surgical methods (CAS and CEA) for high-risk plaque patients with carotid stenosis.

NCT ID: NCT06222853 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Systemic Lupus Erythematosus

Start date: January 4, 2024
Phase: Phase 1
Study type: Interventional

This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset refractory systemic lupus erythematosus.